MCUJF Projected Dividend Yield

Medicure Inc ( OTCBB : MCUJF )

Medicure is a biopharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the U.S. market and sales to the Retail Public of pharmaceutical products. Co.'s focus is the sale and marketing of its cardiovascular products, AGGRASTAT®, ZYPITAMAG® and increasing its e-commerce and mail order pharmaceutical business in U.S. states through Marley Drug. Co.'s commercial product was AGGRASTAT®, a glycoprotein inhibitor, used for the treatment of non ST elevation acute coronary syndrome, including unstable angina, which is characterized by chest pain when one is at rest, and non Q wave myocardial infarction.

20 YEAR PERFORMANCE RESULTS